(Total Views: 685)
Posted On: 07/02/2020 2:43:14 PM
Post# of 145904
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: invisioner #40667
It certainly appears that there may be multiple approaches to combat cytokine storms. Humanigen’s lenzilumab ( I own there stock as well, though a small fraction of my Cytodyn position) has a strong likelihood of helping Covid patients, as well cancer patients experiencing cytokine storm from CAR-T inflammation. Blocking GM-CSF to prevent creation of a cascade of new hyper inflammatory cells has great potential(IMO not to the level of leronlimab/CCR5 blockade.
We should applaud all the emerging therapies (excepting hydroxychloroquine) as it is going to take multiple approaches to win against Covid 19 and whatever comes next.
I don’t believe individual physicians are skewing the investigational process, as much as important governmental officials racing to choose winners wat ahead of the science.
We should applaud all the emerging therapies (excepting hydroxychloroquine) as it is going to take multiple approaches to win against Covid 19 and whatever comes next.
I don’t believe individual physicians are skewing the investigational process, as much as important governmental officials racing to choose winners wat ahead of the science.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)